Levetiracetam USP/EP


PRODUCT OVERVIEW & MOLECULAR STRUCTURE 

Levetiracetam is a pyrrolidine derivative and an antiepileptic drug that functions as a synaptic vesicle protein 2A (SV2A) ligand. It is widely prescribed for the management of focal and generalized seizures. At Zeni Biotech, we manufacture and purify Levetiracetam API at our state-of-the-art facility in GIDC Ankleshwar, ensuring a highly stable, high-purity crystalline solid that meets international pharmacopoeial standards.

Parameter Specification
IUPAC Name (S)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS Registry Number 102767-28-2
EC Number 600-333-3
Empirical Formula C8H14N2O2
Molecular Weight 170.21 g/mol
Appearance White to off-white crystalline powder


ZENI BIOTECH API GRADES 

Micronized Grade: Optimized for rapid dissolution in oral solid dosages. Standard Crystalline Grade: Ideal for stable tablet formulation. KEY CLINICAL APPLICATION

1. Focal Seizures: First-line add-on or monotherapy for focal epilepsy. 
2. Myoclonic Seizures: Highly effective in adjunctive therapy for juvenile myoclonic epilepsy.
3. Generalized Seizures: Approved for tonic-clonic seizure management. SUPPLY CHAIN & ORDERING Documentation: CoA, MSDS, and GMP Compliance Statement provided per batch.